C4 Therapeutics
CCCC
CCCC
115 hedge funds and large institutions have $281M invested in C4 Therapeutics in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 34
41% less capital invested
Capital invested by funds: $476M → $281M (-$194M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
115
Holding in Top 10
1
Calls
$3.53M
Puts
$1.18M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$15M | |
| 3 | +$7.36M | |
| 4 |
O
OrbiMed
New York
|
+$6.99M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.94M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$9.49M | |
| 3 | -$4.37M | |
| 4 |
Citigroup
New York
|
-$3.42M |
| 5 |
Rafferty Asset Management
New York
|
-$2.99M |